Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 19, 2016Journal of Pediatric Gastroenterology and NutritionOpen Access

Infliximab Dosing Strategies and Predicted Trough Exposure in Children With Crohn Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

AFAdam FrymoyerTPTravis L. PiesterKPK.T. Park

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Frymoyer et al. (2016) studied this question.

synapsesocial.com/papers/6a650a80da61d12b2a04ddcdhttps://doi.org/10.1097/mpg.0000000000001123
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Early Infliximab Trough Levels Are Associated with Persistent Remission in Pediatric Patients with Inflammatory Bowel Disease2014 · 155 citations
  2. 2A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease2014 · 101 citations
  3. 3Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient2013 · 348 citations
  4. 4Predicting efficacy of antiinfectives with pharmacodynamics and Monte Carlo simulation2003 · 118 citations
  5. 5Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease2014 · 288 citations